MAINTELYTE

This brand name is authorized in Cyprus, Spain, France, Ireland, Malta, United Kingdom, South Africa

Active ingredients

The drug MAINTELYTE contains a combination of these active pharmaceutical ingredients (APIs):

1 Glucose
UNII LX22YL083G - DEXTROSE MONOHYDRATE

Glucose is frequently used in both adults and children to restore blood glucose concentrations in the treatment of hypoglycaemia resulting from insulin excess or from other causes. The metabolism of glucose is an energy source for the body.

Read about Glucose
2 Sodium chloride
UNII 451W47IQ8X - SODIUM CHLORIDE

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

Read about Sodium chloride
3 Sodium acetate trihydrate
UNII 4550K0SC9B - SODIUM ACETATE
Read about Sodium acetate
4 Potassium chloride
UNII 660YQ98I10 - POTASSIUM CHLORIDE

Potassium plays a vital physiological role in maintenance of normal electrical excitability of nerve and muscle. It is also important in the genesis and correction of imbalances of acid-base metabolism.

Read about Potassium chloride
5 Magnesium chloride hexahydrate
UNII 02F3473H9O - MAGNESIUM CHLORIDE
Read about Magnesium chloride

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
MAINTELYTE Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B05BB02 Electrolytes with carbohydrates B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BB Solutions affecting the electrolyte balance
Discover more medicines within B05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 84093
Country: FR Base de donnรฉes publique des mรฉdicaments Identifier(s): 67968730
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 379955
Country: MT Medicines Authority Identifier(s): MA1277/01901
Country: ZA Health Products Regulatory Authority Identifier(s): F/24/65, W/24/222

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.